Printer Friendly

Browse Barrett-Lee, Peter

1-22 out of 22 article(s)
Title Type Date Words
The changing face of survivorship. Editorial Jul 1, 2010 438
The fresh challenges of treatment resistance. Brief article Sep 1, 2009 232
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Report Sep 1, 2009 327
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption. Brief article Sep 1, 2009 288
Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation? Brief article Mar 1, 2009 241
Breast cancer metastasis suppressor 1 up-regulates mir-146, which suppresses breast cancer metastasis. Brief article Mar 1, 2009 282
A guide to chemotherapy regimens in the treatment of cancer. Dec 1, 2008 318
When can we sound the all-clear? Editorial Sep 1, 2008 686
The humoral immune system has a key prognostic impact in node-negative breast cancer. Report Sep 1, 2008 473
Molecular dependence of estrogen receptor-negative breast cancer on a Notch-survivin signaling axis. Report Sep 1, 2008 425
Stromal gene expression predicts clinical outcome in breast cancer. Report Jun 1, 2008 320
TNK2 preserves EGF receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Report Jun 1, 2008 426
Reversal of the estrogen receptor--negative phenotype in breast cancer and restoration of antiestrogen response. Mar 1, 2008 461
FoxA1 as a lineage-specific oncogene in luminal type breast cancer. Mar 1, 2008 600
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Clinical report Dec 1, 2007 467
Genetic variation in five genes important in telomere biology and risk for breast cancer. Dec 1, 2007 509
A new era for breast cancer therapy. Sep 1, 2007 597
Limited family structure and BRCA gene mutation status in single cases of breast cancer. Clinical report Sep 1, 2007 307
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer. Clinical report Sep 1, 2007 352
2007 American Society of Clinical Oncology (ASCO) annual meeting. Conference notes Jun 1, 2007 1059
HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. Jun 1, 2007 316
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Jun 1, 2007 598

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |